Award
National Institute of Diabetes and Digestive and Kidney Diseases 2R44DK104299-04
An intravascular Bioartificial Pancreas (iBAP)
Recipient
Not Specified
Award Amount
$1,000,000.00
Ceiling
$1,000,000.00
Awarded
July 30, 2025
Identifier
2R44DK104299-04
NIH awarded a $1,000,000 SBIR Phase IIB project to develop a clinical-scale intravascular bioartificial pancreas to improve Type 1 Diabetes outcomes and reduce healthcare costs.
Description
This is a NIH SBIR Phase IIB project for developing a clinical-scale intravascular bioartificial pancreas (iBAP) aimed at improving T1D outcomes and reducing healthcare costs. The project involves advanced silicon nanopore membrane technology and pre-clinical testing to prepare for an IND filing.